Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash from Financing Activities (2021 - 2025)

Historic Cash from Financing Activities for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to -$4.9 million.

  • Biote's Cash from Financing Activities fell 17912.9% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.4 million, marking a year-over-year increase of 3540.79%. This contributed to the annual value of -$76.1 million for FY2024, which is 42908.9% down from last year.
  • As of Q3 2025, Biote's Cash from Financing Activities stood at -$4.9 million, which was down 17912.9% from -$27.2 million recorded in Q2 2025.
  • Biote's 5-year Cash from Financing Activities high stood at $319.0 million for Q1 2021, and its period low was -$329.5 million during Q2 2021.
  • Over the past 5 years, Biote's median Cash from Financing Activities value was -$4.9 million (recorded in 2025), while the average stood at -$4.3 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 12557.09% in 2022, then tumbled by 106591.54% in 2024.
  • Quarter analysis of 5 years shows Biote's Cash from Financing Activities stood at -$5.2 million in 2021, then increased by 23.39% to -$4.0 million in 2022, then soared by 36.49% to -$2.5 million in 2023, then tumbled by 293.43% to -$9.9 million in 2024, then skyrocketed by 50.32% to -$4.9 million in 2025.
  • Its Cash from Financing Activities stands at -$4.9 million for Q3 2025, versus -$27.2 million for Q2 2025 and -$2.3 million for Q1 2025.